Patrys Limited

Patrys Limited has announced the appointment of Brian Leedman as a new director, effective November 10, 2025. The Initial Director’s Interest Notice reveals that Leedman holds no relevant interests in securities or contracts associated with the company, indicating a fresh start for his tenure. This change may influence the company's governance structure. Patrys Limited currently has an average trading volume of 1,073,778 and a market cap of A$12.61M.

Tip Ranks

Patrys Limited Announces New Director Appointment

Patrys Limited has announced its adherence to ASX Corporate Governance Council’s principles in its corporate governance statement for the financial year ending June 30, 2025. This commitment to transparency and accountability is expected to enhance the company's reputation and trust among stakeholders. The current market cap of Patrys Limited is A$4.58M, with a technical sentiment signal indicating a strong sell for its stock (AU:PAB).

Patrys Limited Upholds ASX Governance Standards

Patrys Limited has announced a proposed issue of up to 2,217,946,752 ordinary fully paid shares under a non-renounceable pro rata offer to raise capital. This initiative aims to enhance the company's financial position and support ongoing research and development in the biotechnology sector, particularly in developing antibody-based therapies for cancer treatment. The current market cap of Patrys Limited is A$4.73M, with a technical sentiment signal indicating a strong sell.

Patrys Limited Announces Major Securities Issue to Boost Capital

Patrys Limited has issued 308,362,535 fully paid ordinary shares at $0.001 each to sophisticated and professional investors, as part of a placement to strengthen its financial position in the biotechnology sector. This action complies with the Corporations Act and reflects the company's ongoing efforts to secure funding. Patrys Limited, based in Melbourne, focuses on developing its deoxymab platform of cell-penetrating antibodies for various therapeutic indications. The current market cap is A$3.09M.

Patrys Limited Issues New Shares to Strengthen Financial Position

Patrys Limited (AU:PAB) has announced the immediate lifting of the suspension of trading in its securities on the Australian Securities Exchange (ASX). This decision follows the release of an operations update, which is anticipated to provide crucial insights into the company's current status and future plans, potentially affecting its market position and stakeholder interests. The current market cap of Patrys Limited is A$3.09M.

Patrys Limited Resumes Trading on ASX

Patrys Limited has requested a voluntary suspension of its securities from the Australian Securities Exchange ahead of an operations update announcement. This suspension is intended to ensure compliance with continuous disclosure obligations, with the announcement expected before trading resumes on June 6, 2025. The company, which focuses on developing antibody therapies for cancer treatment, emphasizes its commitment to transparency and regulatory compliance, which may affect its market positioning and stakeholder relations.

Patrys Limited Requests Voluntary Suspension Ahead of Key Announcement

Patrys Limited (AU:PAB) has updated its director's interests, with James Campbell's 11 million unlisted options expiring on December 18, 2024, now lapsed. He retains 17,383,125 fully paid ordinary shares and 25 million unlisted options, exercisable at $0.059, expiring on September 30, 2025. This change may affect investor perceptions of the company's stock performance.